SELLAS Life Sciences
SLS
#6885
Rank
C$0.82 B
Marketcap
C$4.84
Share price
-7.59%
Change (1 day)
125.30%
Change (1 year)

Earnings for SELLAS Life Sciences (SLS)

Earnings in 2025 (TTM): -C$37.87 Million

According to SELLAS Life Sciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$43.19 Million, an increase over its 2023 earnings that were of -C$51.9 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for SELLAS Life Sciences from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$37.87 Million-12.33%
2024 -C$43.19 Million-16.78%
2023 -C$51.9 Million-9.73%
2022 -C$57.5 Million65.85%
2021 -C$34.67 Million48.95%
2020 -C$23.28 Million-1.31%
2019 -C$23.59 Million-44.65%
2018 -C$42.61 Million45.99%
2017 -C$29.19 Million-33.17%
2016 -C$43.68 Million-6.87%
2015 -C$46.9 Million-30.98%
2014 -C$67.96 Million46.52%
2013 -C$46.38 Million
2011 -C$23.03 Million
2008 -C$19.95 Million27.51%
2007 -C$15.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.21 Billion 449.52%๐Ÿ‡บ๐Ÿ‡ธ USA